Abstract

BackgroundThe World Health Organization does not recommend dilatation and sharp curettage (D&C) for the surgical treatment of miscarriage during the first trimester because this may cause Asherman’s syndrome due to endometrial damage; therefore, suction remains the primary treatment option. While manual vacuum aspiration (MVA) has been widely used since the 1990s outside Japan, the use of an MVA device (Women’s MVA system) was approved in Japan in October 2015. Here, we examined the efficacy of the MVA kit in women surgically treated for miscarriage.MethodsThis retrospective cohort study was conducted between 2014 and 2018 at the International University of Health and Welfare Hospital in Japan. Women who underwent surgical treatment for miscarriage within 12 weeks of pregnancy were identified and enrolled in the study. A total of 404 women were included who underwent the following procedures: 121 D&C, 123 electric vacuum aspiration (EVA), and 160 MVA. For each participant, the duration of surgery, amount of bleeding, amount of anesthetic used, incomplete abortion requiring repeat procedures, and intraoperative/postoperative complications were evaluated.ResultsThe duration of surgery was 13.7 ± 7.2, 11.2 ± 4.2, and 6.9 ± 4.3 min in the D&C, EVA, and MVA groups, respectively (p = 1.00). The amount of anesthetic used was not significantly different among all groups. Bleeding of ≥ 100 mL was confirmed in three (2.4%), one (0.8%), and one (0.6%) patient(s) in the D&C, EVA, and MVA groups, respectively (p = 0.50). Incomplete abortion was identified in three (2.4%), two (1.6%), and one (0.6%) patient(s) in the D&C, EVA, and MVA groups, respectively (p = 0.61). However, severe intraoperative/postoperative complications were not observed in any group.ConclusionsSurgical treatment for miscarriage performed using the MVA kit has safety and efficacy similar to those of conventional methods, such as D&C and EVA.

Highlights

  • The World Health Organization does not recommend dilatation and sharp curettage (D&C) for the surgical treatment of miscarriage during the first trimester because this may cause Asherman’s syndrome due to endometrial damage; suction remains the primary treatment option

  • The World Health Organization (WHO) and the International Federation of Gynecology and Obstetrics (FIGO) recommend the use of suction for abortion as well as treatment of miscarriage during the first trimester from the perspective of safety, efficacy, and lower risk of endometrial damage, such as Asherman’s syndrome. These guidelines do not recommend the use of dilatation and sharp curettage (D&C); suction has become the mainstream treatment in Western countries, and manual vacuum aspiration (MVA) has been widely used since the 1990s

  • We introduced the use of the MVA kit at our hospital in June 2016 and have performed surgical treatments for miscarriage during the first trimester using the MVA kit only

Read more

Summary

Introduction

The World Health Organization does not recommend dilatation and sharp curettage (D&C) for the surgical treatment of miscarriage during the first trimester because this may cause Asherman’s syndrome due to endometrial damage; suction remains the primary treatment option. The World Health Organization (WHO) and the International Federation of Gynecology and Obstetrics (FIGO) recommend the use of suction for abortion as well as treatment of miscarriage during the first trimester from the perspective of safety, efficacy, and lower risk of endometrial damage, such as Asherman’s syndrome. These guidelines do not recommend the use of dilatation and sharp curettage (D&C); suction has become the mainstream treatment in Western countries, and manual vacuum aspiration (MVA) has been widely used since the 1990s. We introduced the use of the MVA kit at our hospital in June 2016 and have performed surgical treatments for miscarriage during the first trimester using the MVA kit only.

Methods
Results
Discussion
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.